Treatment.com AI Provides Corporate Update
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its acceleration into the US market. A few key milestones the Company has accomplished are as follows:
- Treatment Provides Platform to Support Healthcare in Nairobi, Kenya
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. - Dr. Kevin Peterson is the Founder and Chief Medical Officer of Treatment.com AI Inc.
- Whilst utilizing AI, the GLM has been curated & evaluated by 150+ physicians globally to be correct, reliable and accurate.
- Treatment’s platform provides clinical decision support to assist the healthcare workers in making an accurate diagnosis.